Baxter International, Inc.
One Baxter Parkway
Deerfield
Illinois
60015
United States
Tel: 847-948-2000
Fax: 847-948-3642
Website: http://www.baxter.com/
About Baxter International, Inc.
Baxter touches millions of lives every day. Our products and services are essential building blocks of healthcare.
You’ll find Baxter’s products and therapies on nearly every floor, in every department, in almost every hospital worldwide. You’ll find us in clinics and in the home. Patients and providers rely on Baxter for lifesaving renal and medical products, including intravenous (IV) solutions, systems and administrative sets, IV infusion parenteral nutrition, perioperative care, pharmacy devices and software, acute renal care, and home and in-center dialysis.
Our mission to save and sustain lives inspires our work and our commitment to expanding access to care, providing cost-effective healthcare solutions, delivering quality products and advancing innovations for the world.
Our commitment to our mission means we are there when patients and healthcare professionals need us, during the critical moments that matter most.
YEAR FOUNDED:
1931
LEADERSHIP:
CEO: José (Joe) E. Almeida
CMO: James R. Gavin III
CTO: Uma Chowdhry
CFO: Peter Hellman
PRODUCTS:
All Products
FOLLOW BAXTER INTERNATIONAL:
Tweets by Baxer International
931 articles with Baxter International, Inc.
-
Baxter International Launches Devicevue Advanced Asset Tracking System For Sigma Spectrum Infusion System
9/27/2017
-
Baxter International Launches First 3-In-1 Set For Use In Continuous Renal Replacement Therapy And Sepsis Management Protocols
9/26/2017
-
Baxter International Parenteral Nutrition Study Describes Lack Of Quality Evidence That Fish Lipid Emulsions Significantly Improve Clinical Outcomes
9/18/2017
-
Baxter International Recognized As Responsible And Sustainable Business For 18thconsecutive Year By Dow Jones Sustainability Index (DJSI)
9/8/2017
-
Baxter International And MATTER Healthcare Incubator Partner On Patient-Driven Innovation
8/31/2017
-
Baxter International And ASPEN Announce Collaboration To Help Reduce Malnutrition Through Appropriate Use Of Parenteral Nutrition Therapy
8/22/2017
-
Baxter International Completes Acquisition Of Claris Injectables, Expanding Generic Injectable Medicines Portfolio
7/27/2017
-
Baxter International Reports Second-Quarter 2017 Results And Provides Updated Financial Outlook For 2017 And 2020
7/26/2017
-
Baxter International Releases Annual Corporate Responsibility Report; Announces Progress Toward Social And Environmental 2020 Goals
7/20/2017
-
Baxter International Declares Quarterly Dividend
7/18/2017
-
Baxter International Appoints Cathy R. Smith to Its Board
7/18/2017
-
FDA Releases Update on Baxter International's Vascu-Guard Patch Recall
7/7/2017
-
Baxter International, RAMOT At Tel Aviv University And Tel Aviv Sourasky Medical Center Partner To Bring New Surgical Innovations Worldwide
7/6/2017
-
Baxter International To Host Second Quarter 2017 Financial Results Conference Call For Investors
6/30/2017
-
Baxter International Announces DoseEdge Bi-Directional Integration With Epic In The Pharmacy
6/26/2017
-
How Baxter International's CEO is Transforming the Company
6/9/2017
-
Should You Bet Along With Hedge Fund Managers On Baxter International?
6/7/2017
-
Baxter International Announces U.S. FDA Approval And Commercial Launch Of Ready-To-Use Clindamycin Injection In Saline
6/7/2017
-
Baxter International Presents Data On Telehealth’s Role In Improving Peritoneal Dialysis Patient Care At ERA-EDTA 2017
6/6/2017
-
New Data Demonstrates High Performance Of Hdx Enabled By THERANOVA, Baxter International’s Novel Hemodialysis Therapy
6/5/2017